Cwm LLC Has $2.29 Million Stock Position in McKesson Co. (NYSE:MCK)

Cwm LLC increased its holdings in McKesson Co. (NYSE:MCK) by 6.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,944 shares of the company’s stock after acquiring an additional 289 shares during the period. Cwm LLC’s holdings in McKesson were worth $2,289,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in MCK. OFI Invest Asset Management bought a new stake in shares of McKesson during the 3rd quarter worth $26,000. Legacy Financial Group LLC bought a new stake in shares of McKesson in the third quarter valued at approximately $27,000. BKM Wealth Management LLC purchased a new stake in shares of McKesson during the 4th quarter valued at approximately $31,000. Avior Wealth Management LLC boosted its holdings in McKesson by 50.0% in the 3rd quarter. Avior Wealth Management LLC now owns 84 shares of the company’s stock worth $37,000 after buying an additional 28 shares during the period. Finally, WASHINGTON TRUST Co grew its stake in McKesson by 42.5% in the 4th quarter. WASHINGTON TRUST Co now owns 114 shares of the company’s stock valued at $53,000 after buying an additional 34 shares in the last quarter. Institutional investors own 85.07% of the company’s stock.

McKesson Trading Up 0.8 %

MCK opened at $539.94 on Friday. The stock has a market capitalization of $70.95 billion, a P/E ratio of 24.46, a PEG ratio of 1.42 and a beta of 0.45. The stock has a 50-day moving average price of $527.50 and a 200-day moving average price of $488.84. McKesson Co. has a 12-month low of $352.34 and a 12-month high of $543.00.

McKesson (NYSE:MCK) last issued its earnings results on Wednesday, February 7th. The company reported $7.74 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.05 by $0.69. The business had revenue of $80.90 billion during the quarter, compared to analyst estimates of $77.93 billion. McKesson had a negative return on equity of 262.63% and a net margin of 0.99%. McKesson’s revenue for the quarter was up 14.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $6.90 earnings per share. On average, equities research analysts predict that McKesson Co. will post 27.59 EPS for the current year.

McKesson Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, July 1st. Shareholders of record on Monday, June 3rd will be paid a $0.62 dividend. This represents a $2.48 annualized dividend and a yield of 0.46%. The ex-dividend date is Monday, June 3rd. McKesson’s dividend payout ratio is presently 11.24%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the company. SVB Leerink initiated coverage on McKesson in a report on Monday, February 26th. They issued an “outperform” rating and a $600.00 price target for the company. Argus raised their target price on McKesson from $510.00 to $570.00 and gave the stock a “buy” rating in a research note on Wednesday, April 10th. Morgan Stanley upped their price target on McKesson from $522.00 to $548.00 and gave the company an “overweight” rating in a research report on Monday, April 15th. UBS Group raised their price objective on shares of McKesson from $575.00 to $620.00 and gave the company a “buy” rating in a research report on Wednesday, March 6th. Finally, Barclays assumed coverage on shares of McKesson in a report on Wednesday, January 3rd. They set an “overweight” rating and a $537.00 target price on the stock. Two research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, McKesson presently has a consensus rating of “Moderate Buy” and a consensus price target of $533.50.

Insider Buying and Selling at McKesson

In other news, EVP Leann B. Smith sold 186 shares of McKesson stock in a transaction dated Tuesday, February 13th. The stock was sold at an average price of $496.00, for a total value of $92,256.00. Following the transaction, the executive vice president now owns 1,511 shares in the company, valued at $749,456. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other McKesson news, CEO Brian S. Tyler sold 3,473 shares of the stock in a transaction on Friday, March 15th. The shares were sold at an average price of $524.55, for a total transaction of $1,821,762.15. Following the completion of the sale, the chief executive officer now owns 43,445 shares of the company’s stock, valued at approximately $22,789,074.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Leann B. Smith sold 186 shares of the business’s stock in a transaction dated Tuesday, February 13th. The shares were sold at an average price of $496.00, for a total transaction of $92,256.00. Following the completion of the transaction, the executive vice president now owns 1,511 shares in the company, valued at approximately $749,456. The disclosure for this sale can be found here. Company insiders own 0.21% of the company’s stock.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.